688767 Hangzhou Biotest Biotech
- 24.82
- +0.06+0.24%
Hangzhou Biotest Biotech News
Guotai Junan Securities Co., Ltd. inspection opinions on the differentiated dividends of Hangzhou Botuo Biotechnology Co., Ltd.
Hangzhou Botuo Biotechnology Co., Ltd. Investor Relations Record Form (2024-003)
Botuo Biotech's announcement on holding results briefings for the first quarter of 2023 and 2024
Announcement of Resolutions of the 10th Meeting of the 3rd Board of Supervisors of Botuo Biotech
Botuo Biotech's announcement on renewing the employment of an accounting firm
Botuo Biotech's special report on the storage and use of funds raised in 2023
Special inspection opinion of Guotai Junan Securities Co., Ltd. on the storage and actual use of funds raised by Hangzhou Botuo Biotechnology Co., Ltd. in 2023
Hangzhou Botuo Biotechnology Co., Ltd. 2023 Audit Report
Hangzhou Botuo Biotechnology Co., Ltd. 2023 Fund Raised Deposit and Use Verification Report
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Hangzhou Botuo Biotechnology Co., Ltd.
2023 Independent Director Debriefing Report (Wang Liang)
Hangzhou Botuo Biotechnology Co., Ltd. Internal Control Audit Report
Special opinion of the board of directors of Hangzhou Botuo Biotechnology Co., Ltd. on the independence of independent directors
Hangzhou Botuo Biotechnology Co., Ltd. 2023 Accounting Firm Performance Evaluation Report
2023 Independent Director Debriefing Report (Wang Wenming)
2023 Independent Director Debriefing Report (Xia Li'an)
2023 Independent Director Debriefing Report (Ying Guoqing)
Guotai Junan Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Hangzhou Botuo Biotechnology Co., Ltd.
Hangzhou Botuo Biotechnology Co., Ltd. Investor Relations Record Form (2024-002)
Guotai Junan Securities Co., Ltd.\'s 2023 Continuous Supervision Work Site Inspection Report on Hangzhou Botuo Biotechnology Co., Ltd.
Analysis
Price Target
No Data
